News
Telehealth company Hims & Hers reported first-quarter results late Monday that beat Wall Street estimates. But parts of the ...
But Hims & Hers' shares fell in after-hours trading as second-quarter projections fell short of analysts' expectations. The ...
Mike Florio and Michael Holley discuss the Kansas City Chiefs' outlook heading into the 2025 season, explaining why the team ...
For San Francisco 49ers fans, Super Bowl LXVII in New Orleans was the first time in nearly two decades the team had a shot at ...
Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...
Seven years after his decision to skip a visit to the White House caused an uproar, former Philadelphia Eagles safety Malcolm ...
Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy ...
Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans. Hims & ...
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...
The companies, which have at times had an adversarial relationship, also said they would develop a roadmap to continue their ...
Hurts and other players cited scheduling conflicts as the reasons for their absences, according to a White House official.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results